5:23 PM ET
10-Q
Financial Results
Oramed Pharmaceuticals Q3 2026 Results: Net Income $18.4M, Down 62.0% YoY
Oramed Pharmaceuticals reported a significant increase in net income to $134.9 million for the nine months ended September 30, 2026, primarily driven by $180.5 million in financial income. The company's total assets grew to $400.9 million, largely due to substantial increases in the fair value of investments and associates.
- Key figure
- Net income $18.4M · -62.0% YoY